Table 1 Patient characteristics
Median age, range (years) | 54 (31–73) |
|---|---|
Performance status (ECOG scale) | Â |
• 0 | 12.2% (9/74) |
• 1 | 81.1% (60/74) |
• 2 | 6.7% (5/74) |
Histologic cell type | Â |
• Serous | 50% (37/74) |
• Endometrioid | 22.97% (17/74) |
• Mucinous | 6.76% (5/74) |
• Clear cell | 4.05% (3/74) |
• Mixed | 13.51% (10/74) |
• Undifferentiated | 1.35% (1/74) |
• Others | 1.35% (1/74) |
FIGO stage at diagnosis | Â |
â–ª I | 8.1% (6/74) |
â–ª II | 12.2% (9/74) |
â–ª III | 58.1% (43/74) |
â–ª IV | 21.6% (16/74) |
Primary surgery | Â |
â–ª Radical | 16.2% (12/74) |
â–ª Optimal debulking | 48.6% (36/74) |
â–ª Suboptimal debulking | 35.1% (26/74) |
Grade (G) | Â |
â–ª 1 and 2 | 41.9% (31/74) |
â–ª 3 and unknown | 58.1% (43/74) |
Platinum sensitivity | Â |
Sensitive (>6 months) | 64.9% (48/74) |
Resistant (<6 months) | 35.1% (26/74) |